Marguerite Koutsoukos

3.8k citations

29 papers · 1.8k indexed · 1 hit paper · h-index 18

Virology top 0.5%
- HIV Research and Treatment 18
Immunology top 2%
- Immune Cell Function and Interaction 10
- Immunotherapy and Immune Responses 4
Infectious Diseases top 2%
- SARS-CoV-2 and COVID-19 Research 3
Epidemiology top 5%
- Hepatitis B Virus Studies 4
- Virology and Viral Diseases 3
Hepatology top 10%
Molecular Biology
- vaccines and immunoinformatics approaches 7
Animal Science and Zoology
- Animal Virus Infections Studies 4

Co-authors: Gérald Voss Paul A. Goepfert David C. Montefiori Jesus F. Salazar-Gonzalez Xiping Wei Julie M. Decker John R. Mascola Miroslawa Bilska
Cited by: Virology Immunology Infectious Diseases
Journals: Nature Communications (2 papers)SHILAP Revista de lepidopterología (1 paper)PLoS ONE (2 papers)
Partner nations: Belgium United States United Kingdom

In The Last Decade

Marguerite Koutsoukos

28 papers receiving 1.8k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Marguerite Koutsoukos

Since Specialization

Citations

This map shows the geographic impact of Marguerite Koutsoukos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marguerite Koutsoukos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marguerite Koutsoukos more than expected).

Fields of papers citing papers by Marguerite Koutsoukos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marguerite Koutsoukos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marguerite Koutsoukos. The network helps show where Marguerite Koutsoukos may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Marguerite Koutsoukos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Marguerite Koutsoukos Line = papers co-authored together Marguerite Koutsoukos links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Beta-containing bivalent SARS-CoV-2 protein vaccine elicits durable broad neutralization in macaques and protection in hamsters SHILAP Revista de lepidopterología ·Catherine Berry,Vincent Pavot,Natalie G. Anosova,Michael Kishko,Lu Li,Tim Tibbitts,Alice Raillard,Sylviane Gautheron,Sheila Cummings,Dinesh S. Bangari,Swagata Kar,Caroline Atyeo,Yixiang Deng,Galit Alter,Cindy Gutzeit,Marguerite Koutsoukos,Roman M. Chicz,Valérie Lecouturier	2023	2
2	Beta variant COVID-19 protein booster vaccine elicits durable cross-neutralization against SARS-CoV-2 variants in non-human primates Nature Communications ·Vincent Pavot,Catherine Berry,Michael Kishko,Natalie G. Anosova,Lu Li,Tim Tibbitts,De-An Huang,Alice Raillard,Sylviane Gautheron,Cindy Gutzeit,Marguerite Koutsoukos,Roman M. Chicz,Valérie Lecouturier	2023	12
3	Protein-based SARS-CoV-2 spike vaccine booster increases cross-neutralization against SARS-CoV-2 variants of concern in non-human primates Nature Communications ·Vincent Pavot,Catherine Berry,Michael Kishko,Natalie G. Anosova,De-An Huang,Tim Tibbitts,Alice Raillard,Sylviane Gautheron,Cindy Gutzeit,Marguerite Koutsoukos,Roman M. Chicz,Valérie Lecouturier	2022	25
4	Persistence of vaccine-elicited immune response up to 14 years post-HIV gp120-NefTat/AS01B vaccination Vaccine ·Olivier Van Der Meeren,Erik Jongert,Kelly E. Seaton,Marguerite Koutsoukos,Annelies Aerssens,Caroline Brackett,Muriel Debois,Michel Janssens,Geert Leroux‐Roels,Doris Mesia Vela,Sheetal Sawant,Nicole L. Yates,Georgia D. Tomaras,Isabel Leroux‐Roels,François Roman	2020	3
5	Selection of HIV vaccine candidates for concurrent testing in an efficacy trial Current Opinion in Virology ·Ying Huang,(unknown),Carlos A. DiazGranados,Holly Janes,(unknown),(unknown),Allan C. deCamp,Barbara Metch,Shannon Grant,Brittany Sanchez,Sanjay Phogat,Marguerite Koutsoukos,Niranjan Kanesa-thasan,Patricia Bourguignon,Alix Collard,Susan Buchbinder,Georgia D. Tomaras,M. Juliana McElrath,Glenda Gray,James G. Kublin,Lawrence Corey,Peter B. Gilbert	2016	7
6	Heterologous Prime-Boost Regimens with a Recombinant Chimpanzee Adenoviral Vector and Adjuvanted F4 Protein Elicit Polyfunctional HIV-1-Specific T-Cell Responses in Macaques PLoS ONE ·Clarisse Lorin,Yannick Vanloubbeeck,Sébastien Baudart,M. Szyman ́ska-Czerwin ́ska,Babak Bayat,Geoffroy Brauers,Géraldine Clarinval,Marie-Noëlle Donner,Martine Marchand,Marguerite Koutsoukos,Pascal Mettens,Joe Cohen,Gérald Voss	2015	9
7	Processing of blood samples influences PBMC viability and outcome of cell-mediated immune responses in antiretroviral therapy-naïve HIV-1-infected patients Journal of Immunological Methods ·Patricia Bourguignon,Frédéric Clément,Frédéric Renaud,Vivien Le Bras,Marguerite Koutsoukos,Wivine Burny,Philippe Moris,Clarisse Lorin,Alix Collard,Geert Leroux‐Roels,François Roman,Michel Janssens,Linos Vandekerckhove	2014	17
8	Immunogenicity of a recombinant measles HIV-1 subtype C vaccine Vaccine ·Richard Stebbings,Bo Li,Clarisse Lorin,Marguerite Koutsoukos,Michèle Février,Edward Mee,Mark Page,Neil Almond,Frédéric Tangy,Gérald Voss	2013	17
9	Safety and immunogenicity of an adjuvanted protein therapeutic HIV-1 vaccine in subjects with HIV-1 infection: A randomised placebo-controlled study Vaccine ·Thomas Harrer,Andreas Plettenberg,Keikawus Arastéh,Jan van Lunzen,Gerd Fätkenheuer,Hans Jaeger,Michel Janssens,Wivine Burny,Alix Collard,François Roman,A Loeliger,Marguerite Koutsoukos,Patricia Bourguignon,Ludo Lavreys,Gérald Voss	2013	15
10	Toxicology, biodistribution and shedding profile of a recombinant measles vaccine vector expressing HIV-1 antigens, in cynomolgus macaques Naunyn-Schmiedeberg s Archives of Pharmacology ·Clarisse Lorin,Lawrence Segal,Johann Mols,Danielle Morelle,Patricia Bourguignon,Olga Rovira,Pascal Mettens,Jérémy Silvano,Nicolas Dumey,Frédérick Le Goff,Marguerite Koutsoukos,Gérald Voss,Frédéric Tangy	2012	18
11	Strong and persistent CD4+ T-cell response in healthy adults immunized with a candidate HIV-1 vaccine containing gp120, Nef and Tat antigens formulated in three Adjuvant Systems Vaccine ·Isabel Leroux‐Roels,Marguerite Koutsoukos,Frédéric Clément,Sophia Steyaert,Michel Janssens,Patricia Bourguignon,Kristen W. Cohen,Marcus Altfeld,Pierre Vandepapelière,Louise Pedneault,Lisa McNally,Geert Leroux‐Roels,Gérald Voss	2010	56
12	The candidate tuberculosis vaccine Mtb72F/AS02A: Tolerability and immunogenicity in humans Human Vaccines ·Kenneth Von Eschen,Royce A. Morrison,Madeleine Braun,Opokua Ofori‐Anyinam,Els De Kock,Priya Pavithran,Marguerite Koutsoukos,Philippe Moris,Daniel Cain,Marie‐Claude Dubois,Joe Cohen,W. Ripley Ballou	2009	89
13	Acute-phase CD4+ T-cell proliferation and CD152 upregulation predict set-point virus replication in vaccinated simian–human immunodeficiency virus strain 89.6p-infected macaques Journal of General Virology ·Gerrit Koopman,Daniëlla Mortier,Sam Hofman,Marguerite Koutsoukos,Willy Bogers,Britta Wahrén,Gérald Voss,Jonathan L. Heeney	2009	4
14	Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers Vaccine ·Pierre Vandepapelière,Yves Horsmans,Philippe Moris,Marcelle Van Mechelen,Michel Janssens,Marguerite Koutsoukos,Pascale Van Belle,Frédéric Clément,Emmanuel Hanon,Martine Wettendorff,Nathalie Garçon,Geert Leroux‐Roels	2008	168
15	Evaluation of two formulations of adjuvanted RTS, S malaria vaccine in children aged 3 to 5 years living in a malaria-endemic region of Mozambique: a Phase I/IIb randomized double-blind bridging trial Trials ·Eusébio Macete,Jahit Sacarlal,John J. Aponte,Amanda Leach,Margarita M. Navia,Jessica Milman,Caterina Guinovart,Inácio Mandomando,Yolanda López‐Púa,Marc Lievens,Alex Owusu‐Ofori,Marie‐Claude Dubois,Conor P. Cahill,Marguerite Koutsoukos,Marla Sillman,Ricardo Thompson,Filip Dubovsky,W. Ripley Ballou,Joe Cohen,Pedro L. Alonso	2007	25
16	Durable HIV-1 antibody and T-cell responses elicited by an adjuvanted multi-protein recombinant vaccine in uninfected human volunteers Vaccine ·Paul A. Goepfert,Georgia D. Tomaras,Helen Horton,David C. Montefiori,Guido Ferrari,Mark Deers,Gérald Voss,Marguerite Koutsoukos,Louise Pedneault,Pierre Vandepapelière,M. Juliana McElrath,Paul Spearman,Jonathan D. Fuchs,Beryl A. Koblin,William A. Blattner,Sharon E. Frey,Lindsey R. Baden,Clayton Harro,Thomas G. Evans	2006	71
17	Potent enhancement of cellular and humoral immune responses against recombinant hepatitis B antigens using AS02A adjuvant in healthy adults Vaccine ·Pierre Vandepapelière,Barbara Rehermann,Marguerite Koutsoukos,Philippe Moris,Nathalie Garçon,Martine Wettendorff,Geert Leroux‐Roels	2004	38
18	Seroprevalence of Herpes Simplex Virus Types 1 and 2 and Cytomegalovirus in Adolescents Clinical Infectious Diseases ·Susan L. Rosenthal,Lawrence R. Stanberry,Frank M. Biro,M. Slaoui,M Francotte,Marguerite Koutsoukos,Molly Hayes,David I. Bernstein	1997	63
19	Polymorphonuclear neutrophils enhance anti-CD3-induced T cell activation: The role of polymorphonuclear FC-receptors Cellular Immunology ·Jacques Bentin,Marguerite Koutsoukos,M. Piérart,Thierry Appelboom,Jan Ceuppens	1991	4
20	Immunopharmacological properties of RES-1080 in vitro Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) ·Thierry Appelboom,Nicole Mairesse,M. Piérart,Marguerite Koutsoukos,Jacques Bentin	1990	0

About Marguerite Koutsoukos

Marguerite Koutsoukos is a scholar working on Virology, Infectious Diseases and Immunology, having authored 29 papers that have together received 1.8k indexed citations. Recurring topics across this work include HIV Research and Treatment (18 papers), Immune Cell Function and Interaction (10 papers), vaccines and immunoinformatics approaches (7 papers), Immunotherapy and Immune Responses (4 papers), Hepatitis B Virus Studies (4 papers), Animal Virus Infections Studies (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Virology and Viral Diseases (3 papers). The work is most often cited by research in Virology (1.0k citations), Immunology (929 citations) and Infectious Diseases (659 citations). Marguerite Koutsoukos has collaborated with scholars based in Belgium, United States and United Kingdom. Frequent co-authors include Gérald Voss, Paul A. Goepfert, David C. Montefiori, Jesus F. Salazar-Gonzalez, Xiping Wei, Julie M. Decker, John R. Mascola, Miroslawa Bilska, Leonidas Stamatatos and Beatrice H. Hahn. Their work appears in journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact